Subcutaneous adipose tissue and systemic inflammation are associated with peripheral but not hepatic insulin resistance in humans

Birgitta W van der Kolk, Marianthi Kalafati, Michiel Adriaens, Marleen M J van Greevenbroek, Nicole Vogelzangs, Wim H M Saris, Arne Astrup, Armand Valsesia, Dominique Langin, Carla J H van der Kallen, Simone J P M Eussen, Casper G Schalkwijk, Coen D A Stehouwer, Gijs H Goossens, Ilja C W Arts, Johan W E Jocken, Chris T Evelo, Ellen E Blaak*

*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

43 Citationer (Scopus)

Abstract

Obesity-related insulin resistance (IR) may develop in multiple organs, representing different etiologies towards cardiometabolic diseases. We identified abdominal subcutaneous adipose tissue (ScAT) transcriptome profiles in relation to liver or muscle IR by means of RNA sequencing in overweight/obese participants of the DiOGenes cohort (n=368). Tissue-specific IR phenotypes were derived from a 5-point oral glucose tolerance test. Hepatic and muscle IR were characterized by distinct abdominal ScAT transcriptome profiles. Genes related to extracellular remodeling were upregulated in individuals with primarily hepatic IR, whilst genes related to inflammation were upregulated in individuals with primarily muscle IR. In line with this, in two independent cohorts, CODAM (n=325) and the Maastricht Study (n=685), an increased systemic low-grade inflammation profile was specifically related to muscle IR, but not to liver IR. We propose that increased ScAT inflammatory gene expression may translate into an increased systemic inflammatory profile, linking ScAT inflammation to the muscle IR phenotype. These distinct IR phenotypes may provide leads for more personalized prevention of cardiometabolic diseases.

DiOGenes was registered at clinicaltrials.gov as NCT00390637.

OriginalsprogEngelsk
TidsskriftDiabetes
Vol/bind68
Udgave nummer12
Sider (fra-til)2247-2258
Antal sider12
ISSN0012-1797
DOI
StatusUdgivet - 2019

Bibliografisk note

CURIS 2019 NEXS 372
© 2019 by the American Diabetes Association.

Citationsformater